David P. Wood

21.0k citations

281 papers · 14.8k indexed · 3 hit papers · h-index 62

Pulmonary and Respiratory Medicine top 0.1%
Surgery top 0.2%
Oncology top 0.5%
Urology top 0.05%
Molecular Biology top 5%

Co-authors: James E. Montie David J. Grignon Wael Sakr Catherine M. Tangen E. David Crawford Nicholas J. Vogelzang Fernando J. Bianco Eric A. Klein
Topics: Prostate Cancer Diagnosis and Treatment (130 papers)Prostate Cancer Treatment and Research (108 papers)Bladder and Urothelial Cancer Treatments (95 papers)
Cited by: Urology Pulmonary and Respiratory Medicine Surgery
Journals: New England Journal of Medicine JAMA Journal of Biological Chemistry
Partner nations: United States Canada Israel

In The Last Decade

David P. Wood

269 papers receiving 14.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

2003 1.8k citations H. Barton Grossman, Ronald B. Natale et al. New England Journal of Medicine profile →
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

2008 1.7k citations Rodney L. Dunn, Eric A. Klein et al. New England Journal of Medicine profile →
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

2011 468 citations Scott E. Eggener, Peter T. Scardino et al. profile →

Peers

Countries citing papers authored by David P. Wood

Since Specialization

Citations

This map shows the geographic impact of David P. Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Wood more than expected).

Fields of papers citing papers by David P. Wood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Wood. The network helps show where David P. Wood may publish in the future.

Co-authorship network of co-authors of David P. Wood

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Wood. A scholar is included among the top collaborators of David P. Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Wood. David P. Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LMP-GAN: Out-of-Distribution Detection for Non-Control Data Malware Attacks 2025 ·IEEE Transactions on Pattern Analysis and Machine Intelligence ·David P. Wood,(unknown),(unknown),Keigo Hirakawa	0
2	Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status 2011 ·Journal of Clinical Oncology ·Walter M. Stadler,Seth P. Lerner,Susan Groshen,John P. Stein,Shan-Rong Shi,Derek Raghavan,David Esrig,Gary D. Steinberg,David P. Wood,Laurence Klotz,(unknown),Donald G. Skinner,Richard J. Côté	165
3	Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917 2011 ·Cancer Prevention Research ·James R. Marshall,Catherine M. Tangen,Wael Sakr,David P. Wood,Donna L. Berry,Eric A. Klein,Scott M. Lippman,Howard L. Parnes,David S. Alberts,David F. Jarrard,W. Robert Lee,J. Michael Gaziano,E. David Crawford,Benjamin Ely,Michael Ray,Warren Davis,Lori M. Minasian,Ian M. Thompson	83
4	A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer 2010 ·Clinical Cancer Research ·Andrew J. Armstrong,George J. Netto,Michelle A. Rudek,Susan Halabi,David P. Wood,Patricia Creel,Kelly Mundy,S. L. Davis,Ting Wang,Roula Albadine,Luciana Schultz,Alan W. Partin,Antonio Jimeno,Helen Fedor,Phillip G. Febbo,Daniel J. George,Robin Gurganus,Angelo M. De Marzo,Michael A. Carducci	62
5	POD-05.08: Predicting the Long-Term Risk of Prostate Cancer-Specific Mortality After Radical Prostatectomy 2009 ·Urology ·Andrew J. Stephenson,Michael W. Kattan,Eric A. Klein,Scott E. Eggener,Peter T. Scardino,James A. Eastham,David P. Wood,Misop Han,Alan W. Partin,Patrick Walsh	1
6	Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer 2008 ·Urologic Oncology Seminars and Original Investigations ·Seth P. Lerner,Catherine M. Tangen,Heidi Sucharew,David P. Wood,E. David Crawford	73
7	Is residual neurovascular tissue on prostatectomy specimens associated with surgeon intent at nerve-sparing and postoperative quality of life measures? 2008 ·Urologic Oncology Seminars and Original Investigations ·Timothy Bradford,Alon Z. Weizer,Scott M. Gilbert,Rodney L. Dunn,Kirk J. Wojno,Rajal B. Shah,David P. Wood	10
8	Fertility Issues for Men with Newly Diagnosed Prostate Cancer 2007 ·Urology ·(unknown),Marcia Leonard,David P. Wood,Timothy G. Schuster	18
9	Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12 2006 ·Human Genetics ·Ethan M. Lange,Lindsey A. Ho,Jennifer Beebe‐Dimmer,Yunfei Wang,Elizabeth M. Gillanders,Jeffrey M. Trent,Leslie A. Lange,David P. Wood,Kathleen A. Cooney	16
10	Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancerbreakdown → 2003 ·New England Journal of Medicine ·H. Barton Grossman,Ronald B. Natale,Catherine M. Tangen,V. O. Speights,Nicholas J. Vogelzang,Donald L. Trump,Ralph W. deVere White,Michael F. Sarosdy,David P. Wood,Derek Raghavan,E. David Crawford	1834
11	Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors. 2001 ·PubMed ·Rafael E. Jiménez,Maha Hussain,Fernando J. Bianco,Ulka N. Vaishampayan,(unknown),Wael Sakr,J. Edson Pontes,David P. Wood,David J. Grignon	198
12	INTRAOPERATIVE, PERIOPERATIVE, AND LONG-TERM COMPLICATIONS OF RADICAL PROSTATECTOMY 2001 ·Urologic Clinics of North America ·Bijan Shekarriz,Jyoti Upadhyay,David P. Wood	51
13	Significance of the Gleason scoring system after neoadjuvant hormonal therapy. 2000 ·PubMed ·(unknown),Jyotirmoy Dey,W A Sakr,David P. Wood,J. Edson Pontes,D J Grignon	12
14	Racial differences and prognostic significance of tumor location in radical prostatectomy specimens 1998 ·The Prostate ·Rabi Tiguert,Edward L. Gheiler,Marcos V. Tefilli,Mousumi Banerjee,David J. Grignon,Wael Sakr,David P. Wood,(unknown),J. Edson Pontes	27
15	Predictors For Maximal Outcome in Patients Undergoing Salvage Surgery For Radio-Recurrent Prostate Cancer 1998 ·Urology ·Edward L. Gheiler,Marcos V. Tefilli,Rabi Tiguert,David J. Grignon,Michael L. Cher,Wael Sakr,J. Edson Pontes,David P. Wood	89
16	Expression and Function of the Leucine Zipper Protein Par-4 in Apoptosis 1997 ·Molecular and Cellular Biology ·Stephen F. Sells,Seong‐Su Han,Sumathi Muthukkumar,(unknown),Ricky W. Johnstone,Erwin R. Boghaert,David Gillis,Guohui Liu,Prakash Nair,(unknown),(unknown),Mark P. Mattson,Vikas P. Sukhatme,Stephen G. Zimmer,David P. Wood,J. William McRoberts,Yang Shi,Vivek M. Rangnekar	159
17	Incidence of urethral involvement in female bladder cancer: An anatomic pathologic study 1997 ·Urology ·(unknown),David P. Wood,David J. Grignon,Mousumi Banerjee,Wael Sakr,J. Edson Pontes	42
18	“Stand-up” urologic endoscopy 1996 ·Urology ·J. William McRoberts,Inderbir S. Gill,(unknown),David P. Wood	2
19	Prostate cancer old problems and new approaches 1996 ·Pathology & Oncology Research ·Kenneth V. Honn,(unknown),Yong Q. Chen,Michael L. Cher,(unknown),Jeffrey D. Forman,Xiang Gao,David J. Grignon,Maha Hussain,Arthur T. Porter,J. Edson Pontes,Isaac J. Powell,Bruce G. Redman,Wael Sakr,Richard K. Severson,Dean G. Tang,David P. Wood	5
20	Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate 1996 ·World Journal of Urology ·(unknown),David P. Wood,Evelyn R. Banks,M. Véron,I. Lascu,(unknown),Vivek M. Rangnekar	16

About David P. Wood

David P. Wood is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 281 papers that have together received 14.8k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (130 papers), Prostate Cancer Treatment and Research (108 papers) and Bladder and Urothelial Cancer Treatments (95 papers). The work is most often cited by research in Urology (2.5k citations), Pulmonary and Respiratory Medicine (7.9k citations) and Surgery (6.2k citations). David P. Wood has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include James E. Montie, David J. Grignon, Wael Sakr, Catherine M. Tangen, E. David Crawford, Nicholas J. Vogelzang, Fernando J. Bianco, Eric A. Klein, J. Edson Pontes and Rodney L. Dunn. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact